Hormone Refractory Prostate Cancer Recruiting Phase 4 Trials for Abiraterone (DB05812)

Back to Hormone Refractory Prostate Cancer

Also known as: Hormone Refractory Prostate Cancer Disease / Hormone-Refractory Prostate Cancer / Castration-resistant prostate cancer / Hormone refractory prostate cancer (disorder)

Indication	Status	Phase
DBCOND0030609 (Hormone Refractory Prostate Cancer)	Recruiting	4

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT03016741	Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer	Supportive Care	Abiraterone (DB05812) Enzalutamide (DB08899) Gonadorelin (DB00644) Prednisone (DB00635)